8-K

                      SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C.  20549



                                   FORM 8-K



                CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)
                    OF THE SECURITIES EXCHANGE ACT OF 1934



                        DATE OF REPORT - July 11, 2001
                        ------------------------------
                       (Date of Earliest Event Reported)



                     NON-INVASIVE MONITORING SYSTEMS, INC.
                     ------------------------------------
            (Exact name of registrant as specified in its charter)



                                    Florida
                          --------------------------
                           (State of Incorporation)



            0-13176                                          59-2007840
     ---------------------                                   ----------
     (Commission File No.)                                (I.R.S. Employer
                                                         Identification No.)



                 1840 West Avenue, Miami Beach, Florida, 33139
                 ---------------------------------------------
              (Address of Principal Executive Offices) (Zip Code)


                                (305) 534-3694
                                ---------------
             (Registrant's telephone number, including area code)


Item 5.   Other Events

     Non-Invasive Monitoring Systems, Inc. (the "Company" or "Nims") announced
the appointment of Allan F. Brack and Dean Kamen to its Board of Directors.

     The Company's press release with respect to the appointment of Allan F.
Brack and Dean Kamen to its Board of Directors is attached hereto as Exhibit
99.1.

Item 7.   Financial Statements and Exhibits.


     (c)  Exhibits.

          99.1 Press Release, dated July 11, 2001.

                                       2


                                  SIGNATURES
                                  ----------

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.



                                   NON-INVASIVE MONITORING SYSTEMS, INC.



Dated: July 17, 2001                             /s/ Marvin A. Sackner
                                                 ---------------------
                                                 Marvin A. Sackner,
                                                 Chairman of the Board

                                       3


    Exhibit                  Description
    -------                  -----------

      99.1                   Press Release, dated July 11, 2001.

EX-99.1

                                 EXHIBIT 99.1
                                 ------------

Non-Invasive Monitoring Systems Announces Appointment Of Allan F. Brack And Dean
Kamen To Its Board Of Directors

MIAMI BEACH, FLORIDA - July 11 2001 - Non-Invasive Monitoring Systems, Inc.
(OTCBB:NIMU) today announced the appointment of Allan F. Brack and Dean Kamen to
its Board of Directors.

Allan F Brack joined Non-Invasive Monitoring Systems, Inc as the Company's Chief
Executive Officer and President, in May 2001. Dr. Marvin Sackner, Chairman of
the Board of Directors commented that Mr. Brack brings a wealth of experience
acquired during 30 years of device sales and marketing as well as in general
management, both in the domestic and international markets. His past
achievements include developing significant dollar sales portfolios for such
products as the Dinamap(R) automatic blood pressure monitors, specialty wearable
pumps from Auto Syringe(R), mechanical ventilators, critical care monitoring,
anesthesia machines, and cardiac ultrasound devices among others. Mr. Brack's
strengths lie in the development of missionary selling and identification of
markets for new innovative device technologies.

Dean Kamen is President and owner of DEKA Research and Development Corporation,
a privately held concern. He is an inventor, an entrepreneur, and an advocate
for science and technology as the founder of FIRST, an organization that uses
marketing and media techniques to motivate the next generation to want to learn
about science and technology. Dean Kamen is also the Chairman and owner of
Teletrol Energy Systems, Inc., a manufacturer of electronic climate control
systems for large commercial and industrial buildings. While still a college
undergraduate, he invented the first wearable infusion pump, which rapidly
gained acceptance from such diverse medical specialties as chemotherapy,
neonatology and endocrinology. In 1976 he founded his first medical device
company, AutoSyringe, Inc., to manufacture and market the pumps. He founded DEKA
Research & Development Corporation to develop internally generated inventions as
well as to provide R&D for major corporate clients. Recent DEKA projects have
included the HomeChoice(TM) dialysis machine, developed for Baxter (Design News'
1993 Medical Product of the Year), and the Independence (3000 IBOT) Transporter,
also developed for Johnson & Johnson. In 1994, Dean Kamen received the Engineer
of the Year Award from Design News magazine. That same year he was elected as a
Fellow of the American Institute of Medical and Biological Engineering. In 1995,
Dean Kamen was awarded the Hoover Medal given by five major engineering
societies for "inventions that have advanced medical care worldwide, and for
innovative and imaginative leadership in awakening America to the excitement of
technology and its surpassing importance in bettering the lot of mankind."

Dr. Sackner commented that Dean Kamen, with his previous experience in
introducing new medical technologies, would provide considerable advice to Non-
Invasive Monitoring Systems in commercializing the Company's novel medical
technologies.

Non-Invasive Monitoring Systems, Inc. is engaged in research, development and
marketing of computer assisted, non-invasive monitoring devices and related
software designed to detect abnormal respiratory, cardiac, and other medical
conditions from sensors placed externally on the body's surface. These devices
provide diagnostic information regarding cardiorespiratory and


sleep disorders in infants, children and adults; in addition, alarms are sounded
for adverse cardiac and respiratory events in critically ill patients. The
Company also has developed a non-invasive, periodic acceleration, motion
platform that it intends to commercialize for treatment of cardiovascular
disease.

Except for historical information, this press release contains, forward-looking
statements regarding the Company's operations, performance, financial condition,
business strategies, margins and sales information and are made pursuant to the
"safe harbor" provisions of the private securities litigation reform act of
1995. For this purpose, any statements contained in this press release that are
not statements of historical fact may be deemed to be forward-looking
statements. These statements by their nature involve substantial risks and
uncertainties, certain of which are beyond the Company's control, and actual
results could differ materially depending on a variety of important factors,
including those described in this press release and the Company's filings with
the Securities and Exchange Commission. The Company undertakes no obligations to
revise or update any forward-looking statements in order to reflect events or
circumstances that may arise after the date of this release.

                                       2